Dublin, July 25, 2022 /PRNewswire/ — The Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunities and Forecast 2022-2027 report has been added to ResearchAndMarkets.com’s offerings.
The global drug delivery market reaches $1,242.8 billion in 2021.Looking ahead, publishers expect the market value to reach $1,753.9 billion The CAGR for 2021-2027 is 5.91% until 2027. Bearing in mind the uncertainties of COVID-19, we are constantly tracking and assessing the direct and indirect impacts of the pandemic on different end-use sectors. These insights are included in the report as key market contributors.
Drug delivery is a method of administering therapeutic substances into the body. It improves efficiency, safety, and patient experience by controlling how quickly, when, and where drug delivery is performed. Currently, different types of drug delivery systems are available to deliver various therapeutic agents. For example, gels, liposomes, microspheres, prodrugs and cyclodextrins are effective systems for peptide and protein therapy.
Rising prevalence of diseases such as respiratory, leishmaniasis, central nervous system (CNS), and systemic fungal infections is one of the key factors driving market growth. In addition, significant increase in mortality of elderly population and cancer patients is driving the demand for drug delivery systems.
These systems provide anticancer agents with enhanced efficacy and reduced toxicity. The market is also influenced by consumers’ inclination towards personalized and minimally invasive (MI) medical treatments. In addition to this, nanoparticles composed of biodegradable polymers are gaining popularity in enhancing drug delivery to the brain. They also assist in meeting the stringent requirements for drug delivery systems imposed by regulatory agencies in many countries.
These requirements typically include stability to the forces generated during nebulization, biocompatibility, targeting specific sites or cell populations in the lung, releasing the drug in a predetermined manner, and degrading within an acceptable time. In line with this, researchers are focusing on developing new drug delivery systems, which is contributing to the market growth.
Furthermore, with the surge in coronavirus disease (COVID-19) cases globally, the demand for the drug is also increasing, which in turn is expected to drive the market growth.
The competitive landscape of the industry is also reviewed along with profiles of key players including AbbVie Inc., Amgen Inc., AstraZeneca plc, Flow Cytometry Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi SA
Key questions answered in this report:
How has the global drug delivery market performed so far and how will it perform in the coming years?
How will COVID-19 impact the global drug delivery market?
What are the major regional markets?
What is the market segmentation based on administrative path?
What is the market segmentation based on application?
What is the market segmentation based on end user?
What are the various stages of the industry value chain?
What are the key drivers and challenges for the industry?
What is the structure of the global drug delivery market? Who are the main players?
How competitive is the industry?
Key topics covered:
2 Scope and method
3 Executive Summary
4 Introduction 4.1 Overview 4.2 Key Industry Trends
5 Global Drug Delivery Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast
6 Market Segmentation by Administration Route 6.1 Oral Drug Delivery 6.1.1 Market Trend 6.1.2 Market Forecast 6.2 Injectable Drug Delivery 6.2.1 Market Trend 6.2.2 Market Forecast 6.3 Topical Drug Delivery 6.3.1 Market Trend 6.3.2 Market Forecast 6.4 Ophthalmic Drug Delivery 6.4.1 Market Trends 6.4.2 Market Forecasts 6.5 Pulmonary Drug Delivery 6.5.1 Market Trends 6.5.2 Market Forecasts 6.6 Implantable Drug Delivery 6.6.1 Market Trends 6.6.2 Market Forecasts 6.7 Transmucosal Drug Delivery 6.7.1 Market Trend 6.7.2 Market Forecast 6.8 Nasal Drug Delivery 6.8.1 Market Trend 6.8.2 Market Forecast
7 Market Segmentation by Application 7.1 Infectious Diseases 7.1.1 Market Trends 7.1.2 Market Forecasts 7.2 Cancer 7.2.1 Market Trends 7.2.2 Market Forecasts 7.3 Cardiovascular Diseases 7.3.1 Market Trends 7.3.2 Market Forecasts 7.4 Diabetes 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Respiratory System Diseases 7.5.1 Market Trend 7.5.2 Market Forecast 7.6 Central Nervous System Disease 7.6.1 Market Trend 7.6.2 Market Forecast 7.7 Autoimmune Disease 7.7.1 Market Trend 7.7.2 Market Forecast 7.8 Others 7.8.1 Market Trend 7.8.2 Market Forecast
8 End User Market Segmentation 8.1 Hospitals 8.1.1 Market Trends 8.1.2 Market Forecasts 8.2 Ambulatory Surgery Centers 8.2.1 Market Trends 8.2.2 Market Forecasts 8.3 Home Care Settings 8.3.1 Market Trends 8.3.2 Market Forecasts 8.4 Diagnostic Centers 8.4. 1 Market trends 8.4.2 Market forecasts 8.5 Others 8.5.1 Market trends 8.5.2 Market forecasts
9 Market Segmentation by Regions
10 SWOT Analysis
11 Value Chain Analysis
12 Porter’s Five Forces Analysis
13 Price Analysis
14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Key Player Profiles 14.3.1 AbbVie Corporation 18.104.22.168 Company Overview 22.214.171.124 Product Portfolio 126.96.36.199 Financials 188.8.131.52 SWOT Analysis 14.3.2 Amgen Corporation 184.108.40.206 Company Overview 220.127.116.11 Product Portfolio 18.104.22.168 Financials 22.214.171.124 SWOT Analysis 14.3.3 AstraZeneca plc 126.96.36.199 Company Overview 188.8.131.52 Product Portfolio 184.108.40.206 Financials 220.127.116.11 SWOT Analysis 14.3.4 Flow Cytometry Dickinson and Company 18.104.22.168 Company Overview 22.214.171.124 Product Portfolio 126.96.36.199 Financials 188.8.131.52 SWOT Analysis 14.3.5 Eli Lilly and Company 184.108.40.206 Company Overview 220.127.116.11 Product Portfolio 18.104.22.168 Financials 14.3.5 .4 SWOT Analysis 14.3. 6 GSK plc 22.214.171.124 Company Overview 126.96.36.199 Product Portfolio 188.8.131.52 Financials 184.108.40.206 SWOT Analysis 14.3.7 Johnson & Johnson 220.127.116.11 Company Overview 18.104.22.168 Product Portfolio 22.214.171.124 Financials 126.96.36.199 SWOT Analysis 14.3. 8 Merck KGaA188.8.131.52 Company Overview 184.108.40.206 Product Portfolio 220.127.116.11 Financials 18.104.22.168 SWOT Analysis 14.3.9 Novartis AG22.214.171.124 Company Overview 126.96.36.199 Product Portfolio 188.8.131.52 Financials 184.108.40.206 SWOT Analysis14.3.10 Pfizer 220.127.116.11 Company Overview 18.104.22.168 Product Portfolio 22.214.171.124 Financials 126.96.36.199 SWOT Analysis14.3.11 Sanofi SA188.8.131.52 Company Overview 184.108.40.206 Product Portfolio 220.127.116.11 Financials
For more information on this report, please visit https://www.researchandmarkets.com/r/2uc4u6
Research and MarketingLaura WoodSenior [email protected]
ET Office Hours +1-917-300-0470 US/Canada Toll Free +1-800-526-8630 GMT Office Hours +353-1-416-8900
U.S. Fax: 646-607-1904 Fax (outside the U.S.): +353-1-481-1716
View original content: https://www.prnewswire.com/news-releases/global-pharmaceutical-drug-delivery-market-2022-to-2027—industry-trends-share-size-growth-opportunity-and- forecast-301592468.html
SOURCE RESEARCH AND MARKET